Marcus Capital’s Merck MRK Stock Holding History

Marcus Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$245K	Buy	+3,616	New	+$230K	0.71%	38

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Marcus Capital's MRK Position: Q3 2018 in Review

Marcus Capital opened a new position in Merck (MRK) in Q3 2018: 3,616 shares worth $245K. The stake represents 0.71% of the portfolio and ranks #38 among its holdings.

2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

Marcus Capital held 3,616 shares of Merck worth $245K as of Q3 2018.
Merck was a new Marcus Capital position in Q3 2018.
Merck made up 0.71% of Marcus Capital's portfolio in Q3 2018, its #38 holding.
2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on Marcus Capital's 13F filing for Q3 2018, filed 13 Nov 2018.